Vimarsana
Biggest News Aggregation in the World

Page 40 - Andreaf Wainer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Andreaf Wainer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Andreaf Wainer Today - Breaking & Trending Today

Abbott Laboratories (NYSE:ABT) Stake Lessened by Assenagon Asset Management S.A. - Vimarsana News

Abbott Laboratories (NYSE:ABT) Stake Lessened by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. lowered its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 21.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 418,751 shares of the healthcare product maker’s stock after selling 117,176 shares during the quarter. Assenagon Asset Management […]

Schechter Investment Advisors LLC Has $6.05 Million Stock Holdings in Abbott Laboratories (NYSE:ABT) - Vimarsana News

Schechter Investment Advisors LLC Has $6.05 Million Stock Holdings in Abbott Laboratories (NYSE:ABT)

Schechter Investment Advisors LLC grew its position in Abbott Laboratories (NYSE:ABT – Free Report) by 11.9% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 54,929 shares of the healthcare product maker’s stock after purchasing an additional 5,835 shares during the period. Schechter Investment Advisors LLC’s […]

Abbott Laboratories (NYSE:ABT) Shares Sold by Kaydan Wealth Management Inc. - Vimarsana News

Abbott Laboratories (NYSE:ABT) Shares Sold by Kaydan Wealth Management Inc.

Kaydan Wealth Management Inc. lessened its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 5.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 2,108 shares of the healthcare product maker’s stock after selling 121 shares during the quarter. Kaydan Wealth […]

Abbott Laboratories (NYSE:ABT) Receives Consensus Recommendation of "Moderate Buy" from Analysts - Vimarsana News

Abbott Laboratories (NYSE:ABT) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Shares of Abbott Laboratories (NYSE:ABT – Get Free Report) have earned an average recommendation of “Moderate Buy” from the thirteen analysts that are currently covering the firm, Marketbeat reports. Four equities research analysts have rated the stock with a hold recommendation and nine have issued a buy recommendation on the company. The average twelve-month price […]

Source: wkrb13.com
Abbott Laboratories (NYSE:ABT) Receives $120.00 Average Price Target from Analysts - Vimarsana News

Abbott Laboratories (NYSE:ABT) Receives $120.00 Average Price Target from Analysts

Shares of Abbott Laboratories (NYSE:ABT – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the thirteen brokerages that are presently covering the company, Marketbeat.com reports. Four equities research analysts have rated the stock with a hold recommendation and nine have issued a buy recommendation on the company. The average 12 month […]